About this FactMed analysis covering adverse side effect reports of ALMARL patients who developed HAEMATEMESIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ALMARL reported HAEMATEMESIS to the FDA. A total of 227 ALMARL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALMARL and HAEMATEMESIS. In doing so, we compare ALMARL with other drugs that cause HAEMATEMESIS, to help you evaluate whether or not ALMARL causes HAEMATEMESIS. Likewise, this page shows the most highly-reported side effects of ALMARL, so you can see if HAEMATEMESIS ranks among ALMARL's most well-known side effects.
Summary Statistics
Reports of ALMARL causing HAEMATEMESIS: 2
Reports of any side effect of ALMARL : 227
Percentage of ALMARL patients where HAEMATEMESIS is a reported side effect: 0.8811%

FDA reports of any drug causing HAEMATEMESIS : 9869
Average percentage for all medicated patients where HAEMATEMESIS is reported as a complication: 0.0619%

Physician opinion on ALMARL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALMARL:
HYPERTENSION ( 76 patients )
PARKINSON'S DISEASE ( 8 patients )
ESSENTIAL TREMOR ( 6 patients )
ATRIAL FIBRILLATION ( 4 patients )
SCHIZOPHRENIA ( 2 patients )
TREMOR ( 2 patients )
ANGINA PECTORIS ( 2 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2 patients )
PALPITATIONS ( 2 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
TACHYCARDIA ( 2 patients )
HYPERTROPHY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HAEMATEMESIS:

ASPIRIN (1478 patients)
HEPARIN SODIUM INJECTION (984 patients)
OMEPRAZOLE (507 patients)
IBUPROFEN (471 patients)
NEXIUM (461 patients)
VIOXX (458 patients)
FOSAMAX (446 patients)
PLAVIX (407 patients)
LASIX (378 patients)
ACETAMINOPHEN (369 patients)
FUROSEMIDE (346 patients)
LISINOPRIL (337 patients)
SIMVASTATIN (324 patients)
LIPITOR (300 patients)
COUMADIN (297 patients)
WARFARIN SODIUM (285 patients)
PREDNISONE (247 patients)
OXYCONTIN (244 patients)
ATENOLOL (238 patients)
NORVASC (233 patients)
ALLOPURINOL (230 patients)
PREDNISOLONE (227 patients)
AMLODIPINE (227 patients)
PROTONIX (224 patients)
RIBAVIRIN (224 patients)
LANSOPRAZOLE (223 patients)
NEURONTIN (218 patients)
ZOMETA (203 patients)
FOLIC ACID (202 patients)
NAPROXEN (202 patients)
PREVACID (201 patients)
SANDOSTATIN LAR (197 patients)
CELEBREX (196 patients)
RAMIPRIL (195 patients)
METHOTREXATE (194 patients)
PRILOSEC (193 patients)
NEXAVAR (192 patients)
DIGOXIN (190 patients)
ENBREL (189 patients)
POTASSIUM CHLORIDE (188 patients)
SEROQUEL (186 patients)
METFORMIN HCL (183 patients)
DEXAMETHASONE (182 patients)
LEVOTHYROXINE SODIUM (180 patients)
LORAZEPAM (179 patients)
PRADAXA (178 patients)
DURAGESIC-100 (178 patients)
GABAPENTIN (174 patients)
ALBUTEROL (174 patients)
FERROUS SULFATE TAB (174 patients)
HUMIRA (171 patients)
HYDROCHLOROTHIAZIDE (170 patients)
PEG-INTRON (170 patients)
FLUOROURACIL (169 patients)
FENTANYL (167 patients)
AMBIEN (166 patients)
GLEEVEC (164 patients)
RANITIDINE (164 patients)
PERCOCET (149 patients)
HEPARIN (148 patients)
VOLTAREN (146 patients)
ZOLOFT (145 patients)
METOCLOPRAMIDE (145 patients)
PANTOPRAZOLE (144 patients)
HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% (143 patients)
DIOVAN (142 patients)
MORPHINE (141 patients)
TRAMADOL HCL (141 patients)
OXYCODONE HCL (137 patients)
PARACETAMOL (134 patients)
METOPROLOL TARTRATE (134 patients)
XANAX (133 patients)
CLOZARIL (133 patients)
ZOCOR (131 patients)
LACTULOSE (131 patients)
LORTAB (130 patients)
ZYPREXA (130 patients)
AREDIA (129 patients)
SPIRONOLACTONE (129 patients)
CISPLATIN (129 patients)
SYNTHROID (128 patients)
CLOPIDOGREL (128 patients)
NITROGLYCERIN (124 patients)
ZANTAC (123 patients)
TYLENOL (CAPLET) (122 patients)
SUTENT (122 patients)
ACETYLSALICYLIC ACID SRT (121 patients)
CYMBALTA (120 patients)
LOVENOX (119 patients)
PEGASYS (117 patients)
LEVAQUIN (115 patients)
ZOFRAN (113 patients)
CLONAZEPAM (112 patients)
DICLOFENAC SODIUM (111 patients)
LYRICA (110 patients)
REVLIMID (110 patients)
ALPRAZOLAM (110 patients)
LEXAPRO (110 patients)
TOPROL-XL (109 patients)
METRONIDAZOLE (109 patients)
ARIXTRA (109 patients)
ACCUTANE (108 patients)
CIPROFLOXACIN (107 patients)
EXJADE (106 patients)
AVASTIN (106 patients)
INSULIN (106 patients)
ALEVE (106 patients)
CITALOPRAM HYDROBROMIDE (104 patients)
PREDNISONE TAB (103 patients)
ATIVAN (102 patients)
ATORVASTATIN CALCIUM (102 patients)
REBETOL (101 patients)
BENADRYL (101 patients)
MULTI-VITAMINS (100 patients)
CALCIUM CARBONATE (100 patients)
CAPECITABINE (99 patients)
CYCLOPHOSPHAMIDE (99 patients)
TEMAZEPAM (99 patients)
REGLAN (97 patients)
BYETTA (96 patients)
PAXIL (96 patients)
AMOXICILLIN (96 patients)
TYLENOL (95 patients)
VITAMIN D (95 patients)
DICLOFENAC (93 patients)
PROZAC (93 patients)
TRAZODONE HCL (92 patients)
FLEXERIL (92 patients)
METOPROLOL (92 patients)
FLUCONAZOLE (91 patients)
GLUCOPHAGE (91 patients)
PANTOPRAZOLE SODIUM (90 patients)
MORPHINE SULFATE (90 patients)
REMICADE (90 patients)
VICODIN (90 patients)
OXALIPLATIN (89 patients)
SENNA (89 patients)
DIAZEPAM (89 patients)
LANTUS (87 patients)
ENOXAPARIN SODIUM (85 patients)
[THERAPY UNSPECIFIED] (85 patients)
CARBOPLATIN (85 patients)
GLYBURIDE (85 patients)
CRESTOR (84 patients)
FORTEO (84 patients)
PROPOFOL (82 patients)
EFFEXOR (81 patients)
PEPCID (81 patients)
VELCADE (80 patients)
ETOPOSIDE (79 patients)
NYSTATIN (79 patients)
CHANTIX (78 patients)
RISPERDAL (78 patients)
COREG (78 patients)
ENALAPRIL MALEATE (77 patients)
DECADRON (77 patients)
RADIATION (77 patients)
RADIOTHERAPY (77 patients)
CLOPIDOGREL BISULFATE (76 patients)
BETASERON (76 patients)
MOBIC (75 patients)
BISOPROLOL FUMARATE (75 patients)
ALDACTONE (74 patients)
EFFEXOR XR (74 patients)
AVONEX (74 patients)
EXELON (74 patients)
ONDANSETRON (73 patients)
CLOZAPINE (73 patients)
METFORMIN (72 patients)
BACTRIM (72 patients)
PRAVASTATIN (71 patients)
ACYCLOVIR (71 patients)
VANCOMYCIN (71 patients)
MAGNESIUM OXIDE (70 patients)
WARFARIN (70 patients)
CELEXA (70 patients)
HEPARIN SODIUM (70 patients)
PROMETHAZINE (70 patients)
FAMOTIDINE (69 patients)
ACTONEL (69 patients)
CALCIUM (68 patients)
AMITRIPTYLINE HCL (68 patients)
MOTRIN (68 patients)
ACTOS (68 patients)
VALIUM (68 patients)
YASMIN (67 patients)
MS CONTIN (67 patients)
COLACE (67 patients)
AMARYL (67 patients)
CLARITIN (66 patients)
DIFLUCAN (66 patients)
COMPAZINE (66 patients)
IRON (66 patients)
QUININE SULFATE (66 patients)
LOPRESSOR (66 patients)
VITAMIN B-12 (65 patients)
ELAVIL (65 patients)
BEXTRA (65 patients)
KLONOPIN (64 patients)
TOCILIZUMAB (64 patients)
AUGMENTIN '125' (64 patients)
SEROQUEL XR (64 patients)
SUNITINIB MALATE (63 patients)
PROPRANOLOL (63 patients)
ACETAMINOPHEN AND CODEINE PHOSPHATE (62 patients)
HYDROCORTISONE (62 patients)
IRESSA (62 patients)
HYDROCODONE (62 patients)
ISOSORBIDE MONONITRATE (61 patients)
KETEK (61 patients)
Most common side effects for patients taking ALMARL:
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
HALLUCINATION (15 patients)
FALL (13 patients)
HYPOGLYCAEMIA (13 patients)
PYREXIA (12 patients)
TREMOR (12 patients)
DIARRHOEA (11 patients)
HEPATIC FUNCTION ABNORMAL (11 patients)
PNEUMONIA (10 patients)
DYSARTHRIA (10 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (9 patients)
RENAL FAILURE ACUTE (9 patients)
LIVER DISORDER (9 patients)
CEREBRAL INFARCTION (8 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (8 patients)
DRUG INEFFECTIVE (8 patients)
RENAL IMPAIRMENT (8 patients)
HYPONATRAEMIA (8 patients)
INTERSTITIAL LUNG DISEASE (8 patients)
JAUNDICE (8 patients)
OEDEMA PERIPHERAL (8 patients)
CONDITION AGGRAVATED (7 patients)
DELIRIUM (7 patients)
DYSPHAGIA (7 patients)
DYSPNOEA (7 patients)
HYPOAESTHESIA (7 patients)
RHABDOMYOLYSIS (7 patients)
VOMITING (6 patients)
DELUSION (6 patients)
RESPIRATORY FAILURE (6 patients)
DYSKINESIA (6 patients)
SOMNOLENCE (6 patients)
HEPATIC NEOPLASM MALIGNANT (6 patients)
HYPERGLYCAEMIA (6 patients)
HYPOKALAEMIA (6 patients)
MOVEMENT DISORDER (6 patients)
MUSCULAR WEAKNESS (6 patients)
WHITE BLOOD CELL COUNT INCREASED (5 patients)
BLADDER CANCER (5 patients)
BLOOD ANTIDIURETIC HORMONE INCREASED (5 patients)
RESTLESSNESS (5 patients)
BLOOD OSMOLARITY DECREASED (5 patients)
PLEURAL EFFUSION (5 patients)
C-REACTIVE PROTEIN INCREASED (5 patients)
CONVULSION (5 patients)
RENAL DISORDER (5 patients)
VITH NERVE PARALYSIS (5 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (5 patients)
INTESTINAL OBSTRUCTION (5 patients)
SEPSIS (5 patients)
ROAD TRAFFIC ACCIDENT (5 patients)
MUSCULOSKELETAL PAIN (5 patients)
NAUSEA (5 patients)
ANOREXIA (4 patients)
ATELECTASIS (4 patients)
ATRIAL FIBRILLATION (4 patients)
ATRIOVENTRICULAR BLOCK (4 patients)
BLOOD CREATININE INCREASED (4 patients)
BRADYCARDIA (4 patients)
CARDIAC FAILURE (4 patients)
CONSTIPATION (4 patients)
DECREASED APPETITE (4 patients)
DEHYDRATION (4 patients)
DIZZINESS (4 patients)
PLATELET COUNT DECREASED (4 patients)
PAIN (4 patients)
HYPERTENSION (4 patients)
HYPOTHYROIDISM (4 patients)
ILEUS (4 patients)
METABOLIC ACIDOSIS (4 patients)
SMALL INTESTINE CARCINOMA (4 patients)
URINE OSMOLARITY INCREASED (4 patients)
ABASIA (3 patients)
AGGRESSION (3 patients)
PRURITUS (3 patients)
ANAEMIA (3 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (3 patients)
WHITE BLOOD CELL COUNT DECREASED (3 patients)
ASTHMA (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
RENAL FAILURE (3 patients)
BLOOD PRESSURE DECREASED (3 patients)
BLOOD PRESSURE INCREASED (3 patients)
VASCULITIS (3 patients)
CAROTID ARTERY STENOSIS (3 patients)
THERAPEUTIC AGENT TOXICITY (3 patients)
CHILLS (3 patients)
CHROMATURIA (3 patients)
PETECHIAE (3 patients)
CHRONIC LYMPHOCYTIC LEUKAEMIA (3 patients)
PORIOMANIA (3 patients)
RENAL ARTERY STENOSIS (3 patients)
PANCYTOPENIA (3 patients)
DRUG ERUPTION (3 patients)
SUDDEN ONSET OF SLEEP (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
VERTIGO (3 patients)
EPILEPSY (3 patients)
FACE OEDEMA (3 patients)
VOLVULUS (3 patients)
GENERALISED OEDEMA (3 patients)
GINGIVAL BLEEDING (3 patients)
HAEMORRHAGE SUBCUTANEOUS (3 patients)
HALLUCINATION, VISUAL (3 patients)
PSYCHIATRIC SYMPTOM (3 patients)
HEART RATE DECREASED (3 patients)
HELICOBACTER TEST POSITIVE (3 patients)
HEPATITIS FULMINANT (3 patients)
HYPERKALAEMIA (3 patients)
HYPOTENSION (3 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (3 patients)
LOSS OF CONSCIOUSNESS (3 patients)
SENSORY DISTURBANCE (3 patients)
LYMPHOMA (3 patients)
MALAISE (3 patients)
MARKEDLY REDUCED DIETARY INTAKE (3 patients)
RENAL TUBULAR DISORDER (3 patients)
NEOPLASM MALIGNANT (3 patients)
SINUS ARREST (3 patients)
ABDOMINAL DISCOMFORT (2 patients)
ABDOMINAL PAIN (2 patients)
ACUTE MYELOID LEUKAEMIA (2 patients)
STOMACH MASS (2 patients)
PERSONALITY CHANGE (2 patients)
AGITATION (2 patients)
ALTERED STATE OF CONSCIOUSNESS (2 patients)
ANAPHYLACTOID REACTION (2 patients)
ANGER (2 patients)
PRODUCTIVE COUGH (2 patients)
RENAL CYST (2 patients)
APHASIA (2 patients)
ASTHENIA (2 patients)
ATRIOVENTRICULAR BLOCK COMPLETE (2 patients)
THIRST (2 patients)
PROSTATE CANCER (2 patients)
BLOOD AMYLASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BODY TEMPERATURE INCREASED (2 patients)
SPEECH DISORDER (2 patients)
TUMOUR LYSIS SYNDROME (2 patients)
CEREBRAL HAEMORRHAGE (2 patients)
CHEST X-RAY ABNORMAL (2 patients)
COLON CANCER (2 patients)
COMA HEPATIC (2 patients)
COMPLETED SUICIDE (2 patients)
CONTUSION (2 patients)
PERFORMANCE STATUS DECREASED (2 patients)
DEFAECATION URGENCY (2 patients)
DEMENTIA ALZHEIMER'S TYPE (2 patients)
RASH PRURITIC (2 patients)
DIABETIC KETOACIDOSIS (2 patients)
DRUG INTERACTION (2 patients)
DRUG LEVEL INCREASED (2 patients)
DYSPEPSIA (2 patients)
DYSSTASIA (2 patients)
ELECTROCARDIOGRAM QT PROLONGED (2 patients)
STEVENS-JOHNSON SYNDROME (2 patients)
EPULIS (2 patients)
EXTRAOCULAR MUSCLE PARESIS (2 patients)
FACIAL PARESIS (2 patients)
FEAR (2 patients)
FEBRILE NEUTROPENIA (2 patients)
FEMORAL NECK FRACTURE (2 patients)
FOOT FRACTURE (2 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (2 patients)
GANGRENE (2 patients)
GASTRIC ULCER HAEMORRHAGE (2 patients)
GINGIVAL HYPERTROPHY (2 patients)
GLOSSOPTOSIS (2 patients)
PLEURISY (2 patients)
PHRENIC NERVE PARALYSIS (2 patients)
HAEMATEMESIS (2 patients)
HAEMATURIA (2 patients)
HAEMOGLOBIN DECREASED (2 patients)
POLLAKIURIA (2 patients)
ORAL INTAKE REDUCED (2 patients)
HEPATIC CYST (2 patients)
HEPATIC ENCEPHALOPATHY (2 patients)
HEPATITIS (2 patients)
HYPERREFLEXIA (2 patients)
HYPERTONIA (2 patients)
HYPERURICAEMIA (2 patients)
RASH PAPULAR (2 patients)
INITIAL INSOMNIA (2 patients)
RETINAL OEDEMA (2 patients)
INTESTINAL FUNCTIONAL DISORDER (2 patients)
RESPIRATION ABNORMAL (2 patients)
IRRITABILITY (2 patients)
RIB FRACTURE (2 patients)
LEG AMPUTATION (2 patients)
LYMPHADENOPATHY (2 patients)
METABOLIC ALKALOSIS (2 patients)
ORAL HERPES (2 patients)
TAKAYASU'S ARTERITIS (2 patients)
MOUTH HAEMORRHAGE (2 patients)
UNRESPONSIVE TO STIMULI (2 patients)
TOXIC SKIN ERUPTION (2 patients)
NEPHROLITHIASIS (2 patients)
SUICIDE ATTEMPT (2 patients)
VENTRICULAR FIBRILLATION (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
UPPER RESPIRATORY TRACT INFECTION (2 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (2 patients)
SHOCK HAEMORRHAGIC (2 patients)
ABDOMEN CRUSHING (1 patients)
CARDIAC FAILURE CONGESTIVE (1 patients)
EOSINOPHILIC PNEUMONIA ACUTE (1 patients)
ESSENTIAL TREMOR (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)
FUNGAL INFECTION (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALMARL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HAEMATEMESIS and ALMARL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALMARL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALMARL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALMARL experts. If you are a healthcare provider experienced in prescribing ALMARL, please register here.

Your online appointment book for Mountain Home Rentals & Services

Chef and Catering services in Mountain Home
Chiropracter and Massage services in Mountain Home
Event and Wedding Planning services in Mountain Home
Hair Styling services in Mountain Home
Personal Shopping services in Mountain Home
Photography and Videography services in Mountain Home
Private Investigation services in Mountain Home
Website Design services in Mountain Home

Home
Appliance Repair services in Mountain Home
Appraisals services in Mountain Home
Awnings services in Mountain Home
Builder Services services in Mountain Home
Carpentry services in Mountain Home
Cleaning services in Mountain Home
Decks and Porches services in Mountain Home
Electricians services in Mountain Home
Fireplace services in Mountain Home
Generators services in Mountain Home
Greenhouses and Nurseries services in Mountain Home
Handymen services in Mountain Home
Home Security services in Mountain Home
HVAC services in Mountain Home
Insulation services in Mountain Home
Interior Design services in Mountain Home
Landscaping services in Mountain Home
Lawn and Yard services in Mountain Home
Locksmiths services in Mountain Home
Marble and Granite Experts services in Mountain Home
Masonry services in Mountain Home
Moving Services services in Mountain Home
Painters services in Mountain Home
Plumbing services in Mountain Home
Pool and Spa services in Mountain Home
Property Management services in Mountain Home
Roofers services in Mountain Home
Snow Plowing services in Mountain Home
Solar Power Consultants services in Mountain Home
Upholstery services in Mountain Home
Wallpaper services in Mountain Home
Waterproofing services in Mountain Home
Windows services in Mountain Home
Services - Other

© 2014 FactMed, Inc
Privacy Policy
Terms of Use